TrialThe Lancet. Oncology2020

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.

Mary W Redman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.